Harmony Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HRMY and other ETFs, options, and stocks.

About HRMY

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the provision of development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors.

CEO

Jeffrey M. Dayno

CEOJeffrey M. Dayno

Employees

268

Employees268

Headquarters

Plymouth Meeting, Pennsylvania

HeadquartersPlymouth Meeting, Pennsylvania

Founded

2017

Founded2017

Employees

268

Employees268

HRMY Key Statistics

Market cap

1.96B

Market cap1.96B

Price-Earnings ratio

13.00

Price-Earnings ratio13.00

Dividend yield

—

Dividend yield—

Average volume

786.57K

Average volume786.57K

High today

$34.50

High today$34.50

Low today

$33.70

Low today$33.70

Open price

$34.00

Open price$34.00

Volume

523.46K

Volume523.46K

52 Week high

$41.61

52 Week high$41.61

52 Week low

$26.47

52 Week low$26.47

Analyst ratings

89%

of 9 ratings

Buy

88.9%

Hold

Sell

11.1%

People also own

Based on the portfolios of people who own HRMY. This list is generated using Robinhood data, and it’s not a recommendation.

Uber

Taiwan Semiconductor Manu…